Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Rises By 680.4%

Novozymes A/S (OTCMKTS:NVZMY) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 43,700 shares, a growth of 680.4% from the December 15th total of 5,600 shares. Based on an average trading volume of 44,200 shares, the days-to-cover ratio is presently 1.0 days.

Analyst Ratings Changes

Several analysts have weighed in on the company. Berenberg Bank upgraded Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th. Barclays upgraded shares of Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Finally, Citigroup downgraded Novozymes A/S from a “neutral” rating to a “sell” rating in a report on Thursday, October 17th.

Novozymes A/S Stock Down 0.8 %

Shares of NVZMY traded down $0.42 during trading hours on Monday, reaching $54.95. 29,596 shares of the company traded hands, compared to its average volume of 26,614. Novozymes A/S has a 12 month low of $49.99 and a 12 month high of $72.50. The company has a market capitalization of $25.73 billion, a price-to-earnings ratio of 34.78, a price-to-earnings-growth ratio of 3.87 and a beta of 0.87. The company’s fifty day moving average price is $57.95 and its two-hundred day moving average price is $62.90.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.